Patents Assigned to Orasis Pharmaceuticals Ltd.
  • Patent number: 11974986
    Abstract: The disclosure relates to ophthalmic pharmaceutical compositions comprising pilocarpine or a pharmaceutically acceptable salt. Aspects of the disclosure further relate to uses and preparations of ophthalmic pharmaceutical compositions comprising pilocarpine or a pharmaceutically acceptable salt, for correcting presbyopia and other ocular conditions in a subject.
    Type: Grant
    Filed: July 27, 2021
    Date of Patent: May 7, 2024
    Assignee: Orasis Pharmaceuticals Ltd.
    Inventors: Claes Feinbaum, Franc Salamun, Sudhir Patel
  • Patent number: 11129812
    Abstract: The disclosure relates to ophthalmic pharmaceutical compositions comprising pilocarpine or a pharmaceutically acceptable salt. Aspects of the disclosure further relate to uses and preparations of ophthalmic pharmaceutical compositions comprising pilocarpine or a pharmaceutically acceptable salt, for correcting presbyopia and other ocular conditions in a subject.
    Type: Grant
    Filed: March 26, 2020
    Date of Patent: September 28, 2021
    Assignee: ORASIS PHARMACEUTICALS LTD.
    Inventors: Claes Feinbaum, Franc Salamun, Sudhir Patel
  • Patent number: 10639297
    Abstract: The disclosure relates to ophthalmic pharmaceutical compositions comprising pilocarpine or a pharmaceutically acceptable salt. Aspects of the disclosure further relate to uses and preparations of ophthalmic pharmaceutical compositions comprising pilocarpine or a pharmaceutically acceptable salt, for correcting presbyopia and other ocular conditions in a subject.
    Type: Grant
    Filed: July 10, 2018
    Date of Patent: May 5, 2020
    Assignee: Orasis Pharmaceuticals Ltd.
    Inventors: Claes Feinbaum, Franc Salamun, Sudhir Patel
  • Patent number: 9867810
    Abstract: The disclosure relates to ophthalmic pharmaceutical compositions comprising pilocarpine or a pharmaceutically acceptable salt. Aspects of the disclosure further relate to uses and preparations of ophthalmic pharmaceutical compositions comprising pilocarpine or a pharmaceutically acceptable salt, for correcting presbyopia and other ocular conditions in a subject.
    Type: Grant
    Filed: August 18, 2017
    Date of Patent: January 16, 2018
    Assignee: Orasis Pharmaceuticals Ltd.
    Inventors: Claes Feinbaum, Franc Salamun, Sudhir Patel